NASDAQ Composite ended the session with Arena Pharmaceuticals jumping 1.56% to $77.67 on Wednesday, following last session’s downward trend. NASDAQ Composite jumped 0.15% to $12,869.34, following last session’s downward trend on what was a somewhat positive trend trading session today.
Arena Pharmaceuticals today’s close was $77.67, 16.12% under its 52-week high of $90.19.
Arena Pharmaceuticals’s Sales
Arena Pharmaceuticals’s sales growth is a negative 81.3% for the current quarter and 155.7% for the next. The company’s growth estimates for the ongoing quarter is a negative 4.5% and positive 4.5% for the next.
Arena Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.
Arena Pharmaceuticals’s last day, last week, and last month’s average volatility was a negative 2.58%, a positive 0.82%, and a positive 0.72%, respectively.
Arena Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 5.51%, 3.85%, and 3.38%, respectively.
Arena Pharmaceuticals’s Stock Yearly Top and Bottom Value
Arena Pharmaceuticals’s stock is valued at $77.67 at 16:06 EST, way below its 52-week high of $90.19 and way above its 52-week low of $32.95.
Arena Pharmaceuticals’s Moving Average
Arena Pharmaceuticals’s worth is way above its 50-day moving average of $69.10 and way above its 200-day moving average of $70.13.